Cutting Edge Information

Sanofi bets on virtual clinical trials

Monday, March 13, 2017

The clinical research industry is facing a crisis. Nearly 80% of trials do not meet enrollment timelines, and these delays can amount to $8 million in lost revenue per day, according to one estimate by Cutting Edge Information. But now the industry is betting on a new trend: virtual clinical research.

[Read More]

Renewed attention for investigator-initiated trials

Tuesday, December 15, 2015

After a five- to eight-year decline, investigator-initiated trials (IITs) are gaining renewed interest as more biopharmaceutical companies are using them as a creative and cost-effective way to innovate and further improve patient safety.

[Read More]

Study: Long-term eTMF maintenance essential for life science companies

Friday, November 13, 2015

As part of good clinical practice (GCP), life sciences teams must develop trial master files (TMFs) and maintain the documents well after the product launch window. Historically, such files were comprised largely of paper-based documents. According to a new study by Cutting Edge Information, however, surveyed global teams report that each of their current TMFs is 54% electronic-based. And that portion is expected to increase to 88% by 2020.

[Read More]

Report examines brand committees

Thursday, August 27, 2015

Life sciences organizations typically implement cross-functional brand commercialization committees to drive product development and maximize commercial success, according to a new study by pharmaceutical intelligence firm Cutting Edge Information. Those groups often are tasked with making key brand strategy decisions and with coordinating a broad range of brand activities throughout the product lifecycle.

[Read More]

Phase I and II clinical trial budgets double over past five years due to staffing, patient enrollment

Monday, June 8, 2015

Early phase clinical trial budgets climbed dramatically during the recent five year period, rising 157% from 2008 to 2013, largely due to increased clinical research associate (CRA) costs and higher per patient costs, according to a just-released study by life sciences intelligence firm Cutting Edge Information. Phase II clinical trial costs also doubled during the same time period.

[Read More]